(Q53515241)
Statements
Quality of life assessment in patients with hormone-resistant prostate cancer treated with epirubicin or with epirubicin plus medroxy progesterone acetate - is it feasible? (English)
G van Andel
K H Kurth
R L Rietbroek
J A van De Velde-Muusers
1 September 2000
38
3
259-264